Endocrine System

Title
Assisted Conception - Commissioning Policy v1.4
Continuous Glucose Monitoring in Children and Young People - Commissioning Policy v3
Continuous Glucose Monitoring during Pregnancy for People with Insulin Treated Diabetes Mellitus - Commissioning Policy v3
Continuous Subcutaneous Insulin Infusion (CSII) In Adults - Commissioning Policy v1.3
Cryopreservation - Commissioning Policy v1.3
Denosumab (Prolia) - Osteoporosis in Men and Postmenopausal Women - Prescribing Guidance v1.7
Finerenone Support Document v1.0
GLP-1 Receptor Agonists in Type 2 Diabetes - Prescribing Guideline v2.1
Hybrid Closed Loop - Position Statement v3.0
I-Port Advance - Position Statement v1.3
Insulin Biosimilar Trurapi Switch Plan v1.1
Intermittently Scanned (Flash) Continuous Glucose Monitoring in Adults - Commissioning Policy v4
NHSE Commissioning recommendations following the national assessment of blood glucose & ketone meters, testing strips and lancets (12th October 2023)
Non Core Gender Reassignment Interventions - Commissioning Policy v1.4.1
Osteoporosis - Management & Treatment in Primary Care Guidance v2.0
Real Time Continuous Glucose Monitoring in Adults - Commissioning Policy v2
Reversal of Sterilisation - Commissioning Policy v1.5
Semaglutide for weight management - ICB Commissioning Position Statement v1
Weight Management (Adults) - Herefordshire Services v1.1
Weight Management (Adults) - Worcestershire Services v1.3
Weight Management and Bariatric Surgery v2.1

Back to Clinical and Prescribing Policies, Guidance and Pathways

Reducing health inequalities

Digital innovation

Health and care services